医学
无症状的
血运重建
心脏病学
血糖性
药物治疗
狭窄
内科学
冲程(发动机)
重症监护医学
心肌梗塞
胰岛素
机械工程
工程类
出处
期刊:Stroke
[Lippincott Williams & Wilkins]
日期:2021-06-01
卷期号:52 (6): 2191-2198
被引量:7
标识
DOI:10.1161/strokeaha.120.033994
摘要
Asymptomatic carotid stenosis (ACS) due to atherosclerosis is a risk factor for ipsilateral ischemic cerebrovascular events and cognitive impairment. The prognosis of ACS has improved over the past 4 decades due largely to improvements in medical management. Most patients with ACS can be managed without revascularization, but some patients with vulnerable plaque should be considered for revascularization. Regardless of the decision to refer for revascularization, all patients with ACS should receive intensive medical management. This includes lifestyle modification (Mediterranean diet, exercise, and smoking cessation) and pharmacological therapy (antiplatelets, lipid-lowering agents, blood pressure reduction, and glycemic control). Patients with ACS often have atherosclerosis in other critical locations, and thus optimal medical therapy is likely to reduce events outside the carotid arteries. The nature of optimal medical therapy is described.
科研通智能强力驱动
Strongly Powered by AbleSci AI